NASDAQ:FDMT | Profit Breakdown | 4D Molecular Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$3.78M-$77.03M-$72.94M
2026-03-31$3.05M-$73.62M-$68.76M
2025-12-31$85.09M$14.72M$19.4M
2025-09-30$90,000.00-$61.19M-$56.88M
2025-06-30$15,000.00-$59.46M-$54.66M
2025-03-31$14,000.00-$53.62M-$47.97M
2024-12-31$1,000.00-$56.12M-$49.67M
2024-09-30$3,000.00-$51.13M-$43.84M
2024-06-30$5,000.00-$42.46M-$34.95M
2024-03-31$28,000.00-$38.14M-$32.4M
2023-12-31-$19,000.00-$36.65M-$32.28M
2023-09-30$20.2M-$13.97M-$10.26M
2023-06-30$239,000.00-$32.14M-$29.62M
2023-03-31$298,000.00-$30.11M-$28.68M
2022-12-31$1.25M-$28.72M-$27.38M
2022-09-30$500,000.00-$26.5M-$25.69M
2022-06-30$162,000.00-$28.43M-$28.09M
2022-03-31$1.22M-$26.39M-$26.34M
2021-12-31$92,000.00-$24.76M-$25.08M
2021-09-30$1.37M-$22.66M-$22.24M
2021-06-30$14.58M-$7.6M-$7.59M
2021-03-31$2M-$16.31M-$16.41M
2020-12-31-$977,000.00-$20.42M-$20.55M
2020-09-30$7.42M-$7.82M-$7.83M
2020-06-30$3.51M-$15.15M-$15.15M
2020-03-31$3.41M-$13.28M-$13.16M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$85.21M-$159.55M-$140.11M
2024-12-31$37,000.00-$187.84M-$160.87M
2023-12-31$20.72M-$112.87M-$100.84M
2022-12-31$3.13M-$110.03M-$107.49M
2021-12-31$18.04M-$71.33M-$71.32M
2020-12-31$13.36M-$56.66M-$56.69M
2019-12-31$6.96M-$50.76M-$49.31M